Cargando…

Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid

INTRODUCTION: The purpose of this research is to assess the effects of oral ibandronate on bone microarchitecture by using high-resolution peripheral quantitative computed tomography (HR-pQCT) in patients with systemic lupus erythematosus (SLE) taking a long-term glucocorticoid. METHODS: In this dou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Edmund K, Zhu, Tracy Y, Hung, Vivian Y, Kwok, Anthony W, Lee, Vivian W, Lee, Kenneth K, Griffith, James F, Li, Martin, Wong, Kong Chiu, Leung, Ping Chung, Qin, Ling, Tam, Lai Shan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991035/ https://www.ncbi.nlm.nih.gov/pubmed/20964867 http://dx.doi.org/10.1186/ar3170

Ejemplares similares

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis
por: Nakamura, T., et al.
Publicado: (2015)

Effect of ibandronate on bending strength and toughness of rodent cortical bone: Possible implications for fracture prevention
por: Savaridas, T., et al.
Publicado: (2015)

Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
por: Kaneko, Kaichi, et al.
Publicado: (2021)

Immunopathological Roles of Cytokines, Chemokines, Signaling Molecules, and Pattern-Recognition Receptors in Systemic Lupus Erythematosus
por: Yu, Shui-Lian, et al.
Publicado: (2012)

Effect of lumbar spinal stenosis on bone mineral density in osteoporosis patients treated with ibandronate
por: Park, Hyung-Youl, et al.
Publicado: (2021)

Neonatal Lupus Erythematosus
por: Lun Hon, Kam, et al.
Publicado: (2012)

Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues
por: Porta, Sabrina, et al.
Publicado: (2020)

Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts
por: Zhang, Xiaohui, et al.
Publicado: (2011)

The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta
por: Ipach, Ingmar, et al.
Publicado: (2012)

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
por: Blachut, Dominika, et al.
Publicado: (2022)

Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus
por: Karoonkatima, Matee, et al.
Publicado: (2023)

Low‐Density Neutrophils in Systemic Lupus Erythematosus
por: Tay, Sen Hee, et al.
Publicado: (2020)

Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model
por: Chung, Yoon-Sok, et al.
Publicado: (2015)

Treatment of Polyostotic Fibrous Dysplasia With Intravenous Ibandronate
por: Kazi, Fatima M, et al.
Publicado: (2021)

Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy
por: Pan, Lu, et al.
Publicado: (2023)

Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese
por: Chang, Y K, et al.
Publicado: (2009)

Systemic Lupus Erythematosus and Immunodeficiency
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus.
por: Choi, M. Y., et al.
Publicado: (1993)

LUPUS PANNICULITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
por: Patel, Raksha M, et al.
Publicado: (2010)

Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy
por: Rentero, Maria Luz, et al.
Publicado: (2015)

Risk and Factors associated with disease manifestations in systemic lupus erythematosus – lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients
por: Chan, Shirley C. W., et al.
Publicado: (2023)

Linear scleroderma occurring in a patient with systemic lupus erythematosus--short report.
por: Lee, C. W., et al.
Publicado: (1994)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Bone mineral density in patients with juvenile systemic lupus erythematosus
por: Guenka, Ana Paula Roenick, et al.
Publicado: (2011)

Bone mineral density in patients with juvenile systemic lupus erythematosus
por: Guenka, Ana Paula Roenick, et al.
Publicado: (2012)

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
por: Teixeira, Vítor, et al.
Publicado: (2018)

Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis
por: Ma, Zeren, et al.
Publicado: (2016)

A case report of systemic lupus erythematosus combined with central serous chorioretinopathy treated with glucocorticoids
por: Rao, Qingqing, et al.
Publicado: (2023)

Impact of climate factors and climate–gene interaction on systemic lupus erythematosus patients' response to glucocorticoids therapy
por: Zhang, Tingyu, et al.
Publicado: (2023)

Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
por: Huang, Duo, et al.
Publicado: (2018)

Ancestry, ACKR1 and leucopenia in patients with systemic lupus erythematosus
por: Chung, Cecilia P, et al.
Publicado: (2022)

Local Application of Ibandronate/Gelatin Sponge Improves Osteotomy Healing in Rabbits
por: Yang, Zongyou, et al.
Publicado: (2015)

Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
por: Devitt, Bianca, et al.
Publicado: (2008)

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
por: Ralston, S. H., et al.
Publicado: (1997)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007)

Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
por: Derman, Richard, et al.
Publicado: (2009)

Ibandronate: The loading dose concept in the treatment of metastatic bone pain
por: Maier, Gerrit Steffen, et al.
Publicado: (2015)

A case report of lupus erythematosus tumidus converted from discoid lupus erythematosus
por: Chen, Xiaomei, et al.
Publicado: (2018)

Cortical Thickness and Subcortical Gray Matter Reductions in Neuropsychiatric Systemic Lupus Erythematosus
por: Jung, Rex E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_em78noofk01bsgm638sg6p8uni